ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Senior Vice President, Clinical Development at Recursion - ApplyBlast

Senior Vice President, Clinical Development

Recursion

1 day ago

3.4 on Glassdoor

New York, New York, United States

Onsite

Full Time

Executive

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

Recursion is seeking an accomplished clinical development leader to serve as Senior Vice President, Clinical Development, responsible for driving the clinical execution of the company's differentiated pipeline across oncology and rare disease. This senior operational and strategic role involves leading a team of clinical scientists and medical directors while embedding AI and machine learning into trial design and execution. The position reports directly to the Chief Medical Officer and plays a central role in advancing clinical programs to support regulatory approval and pipeline strategy.

Responsibilities

Lead clinical strategy and execution for oncology and rare disease programs
Define clinical development strategy including study design and regulatory pathways
Partner with cross-functional teams to embed AI and digital tools in clinical trials

Skills

Qualifications

MDMD/PhD

About Recursion

recursion.com

Headquarters

Salt Lake City, Utah, United States

Company Size

501-1000 employees

Founded

2013

View Profile

Recursion is a TechBio company that combines high-throughput experimental biology, automated imaging, and machine learning to decode biology and accelerate drug discovery. Its platform integrates large-scale biological datasets, AI models, and laboratory automation to identify and advance therapeutic candidates across multiple modalities and disease areas. Recursion develops an internal pipeline of programs and partners with biopharma and investors to translate discoveries into clinical-stage medicines. The company emphasizes a platform-first, scalable approach to make drug discovery faster, more reproducible, and more data-driven.